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Using our in vitro model of normal B cell infection, we investigated whether cellular interactions and/or cytokines directing
the B cell response also regulate HIV replication. Phorbol esters and CD40 Ab plus IL4, added prior to infection, substantially
increased subsequent viral replication. Postinfection, IL2 with or without IL4 and, to a lesser extent, CD40/CD40L interactions
enhanced viral replication. In contrast, IL10 down-regulated HIV replication induced by cytokines, without affecting spontane-
ous or CD40 Ab-induced replication. Both enhancing and inhibitory effects of cytokines on viral replication were independent
of their ability to modulate B cell proliferation. Thus, these two phenomena seem to be independently regulated in human
B cells. q 1996 Academic Press, Inc.
INTRODUCTION and cytokine production (Butch et al., 1993; Foy et al.,
1994; Fuller et al., 1993; Thorbecke et al., 1994). In
Normal human B cells can be infected in vitro by HIV,
physiological conditions, some of these cytokines di-
allowing viral replication and the production of infectious
rect immunoglobulin production toward particular iso-
virus (Gras et al., 1993). In this model, infection of B cells
types (Banchereau et al., 1994), whereas others con-
requires opsonization of the virus by heat-inactivated se-
trol the production of specialized B cell subsets (Arpin
rum from a HIV-1-positive patient and human comple-
et al., 1995; Banchereau et al., 1994). HIV infection
ment as described for macrophage infection (Dierich et
may induce a local imbalance between Th1 (IL2, IFNg)
al., 1993; Thieblemont et al., 1993). In vitro B cell infection
and Th2 (IL4, IL5, IL10, IL13) cytokines (Dalgleish,
requires CD4 and/or the CD21/CD35 complex which
1995; Maggi et al., 1994; Mosmann, 1994), favoring
allow virus entry (Legendre et al., 1996). Although used
immunological disorders such as hypergammaglobu-
to study in vitro B cell infection, our model may mimic in
linemias, hyper-IgE syndromes, autoimmune disor-
vivo conditions in germinal centers (GC), where B cells
ders (Amadori and Chieco-Bianchi, 1990; Ditzel et al.,
interact with follicular dendritic cells (FDC) (Schriever
1994; Martinez-Maza et al., 1987; Muller et al., 1993),
and Nadler, 1992; Thorbecke et al., 1994). Indeed, early
and abnormalities in repertoire selection (VH3) (Ber-
in the course of HIV infection, virus in lymphoid tissue is
berian et al., 1993, 1991). Cell – cell interactions
concentrated within lymphoblastic follicles (Biberfeld et
through CD40/CD40L are also required for GC forma-
al., 1987). This may reflect accumulation of opsonized
tion, isotype switching, and the induction of memory
virus on the surface of FDC (Joling et al., 1993; Pantaleo
B cells (Butch et al., 1993; Durie et al., 1994; Gray et
et al., 1993a; Schmitz et al., 1994). The FDC network is
al., 1994; Muro-Macho et al., 1995; Nishioka and Lip-
subsequently disorganized and destroyed through com-
sky, 1993; Thorbecke et al., 1994), but prevent plasma
plex mechanisms (Fuller et al., 1993; Muro-Macho et al.,
cell production (Arpin et al., 1995; Gray et al., 1994).
1995). However, whether B cells are infected in vivo re-
GC are pivotal in the control of events leading to
mains unclear.
normal B cell differentiation and are major sites of
Within GC, B cells interact with antigen-specific T
HIV loading, spreading, and replication (Schmitz et al.,
helper (Th) cells (Fuller et al., 1993; Thorbecke et al.,
1994; Pantaleo et al., 1993a, 1993b, 1994; Embretson
1994). Although rare, Th cells play a major role in the
et al., 1993). It may thus be valuable to test whether
formation of GC, and control B cell differentiation and
cytokines and cell – cell interactions required for B cell
the humoral response through cell – cell interactions
differentiation also regulate HIV replication in B cells.
Using our in vitro infection model, we tested to what
extent infection leads to an impaired B cell response1 This work was supported by grants from the Agence Nationale
de Recherche sur le SIDA, Ensembles contre le SIDA, the Institut to cytokines and/or CD40 triggering. IL2 and/or IL4, in
National de la Sante´ et de la Recherche Me´dicale and the Universite´
the presence or absence of CD40 Ab, increased HIVParis-Sud.
replication in B cells. In contrast, IL10 inhibited cyto-2 To whom correspondence and reprint requests should be ad-
dressed. Fax: (33-1) 46 32 79 93. kine-induced HIV replication without altering basal or
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CD40-induced viral replication. In B cells, proliferation in the presence of PHA (Wellcome, 5 mg/ml) for 3 days.
Activated or resting T cells were extensively washed andand HIV replication appeared to be independently reg-
ulated by cytokines. g-irradiated at 50 grays (131Cesium source) and added
to infected B cells.
MATERIALS AND METHODS
Infection protocol
Cell preparations
Complement-mediated, antibody-dependent enhance-
ment (C*-ADE) conditions were used for infection. TheHuman mononuclear cells were obtained from tonsils
LAI strain of HIV-1 was used at 50 tissue culture infectiveremoved from HIV-seronegative children with chronic
doses 50% (TCID50 ) per million cells, as determined bytonsillitis. B cell populations were isolated after two cy-
limiting dilution microtiter assay on MT2 cells (positivitycles of rosette formation with aminoethyl isothiouronium
of each well determined on Day 7 postinfection). Beforebromide hydrobromide-treated sheep red blood cells and
infection, the virus was pretreated for 30 min at 47 withan 1-hr cycle of plastic adherence in the presence of
HIV-positive heat-inactivated serum (1/10), and normal10% heat-inactivated fetal calf serum (FCS) as described
serum (1/15) as source of complement, in a final volumepreviously (Richard et al., 1987). The resulting B cell pop-
of 100 ml per 50 TCID50 . For cell infection, each virusulations, consistently containing ⁄95% CD19/, 1%
preparation was added to viable cells (5 1 106 cells/CD3/, and £2% CD14/ cells, were frozen until use. T
ml) and incubated for 30 min at 377. As controls, mockcells were recovered from the first rosetting cell fraction,
infections were performed with heat-inactivated viruswashed and frozen until use. T cell fractions contained
(567, 30 min). Cells were then washed three times andat least 95% CD3/ and 1 to 5% CD14/ cells.
cultured as described above. Each infection condition
was tested in triplicate.Cell culture
Serum from an asymptomatic patient was used to sup-
After thawing, B cells were cultured in RPMI 1640 me- ply enhancing antibodies in all infection experiments.
dium supplemented with 2 mM L-glutamine, 100 mg/ml The neutralization titer of the serum, measured in the
streptomycin, 100 U/ml penicillin, 10 mM HEPES, and MT2 microtiter assay, was 100 in the absence of C*. The
10% FCS (complete medium). In most experiments, B C*-ADE titer was 62,500 in the presence of 1/20 (v/v)
cells were subjected to various stimuli before HIV infec- normal fresh human serum (C*).
tion (primary cultures) and then exposed to various com-
binations of cytokines and/or antibodies after infection Virus detection by p24 capture assay
(secondary cultures).
Major core protein p24 production was assessed byPrimary cultures. B cells (106 cells/ml) were activated
measuring its concentration in culture supernatants, us-by PMA or PDB (Sigma, 5 ng/ml), PDB (1 ng/ml) and
ing a p24 antigen capture assay (DuPont de Nemours,ionomycin (Sigma, 800 ng/ml), SAC (Calbiochem Corp.,
Les Ulis, France). p24 production was tested at variousLa Jolla, CA; 1004 v/v), insoluble goat anti-IgM (Irvine
times postinfection as indicated.Scientific, Santa-Anna, CA; 10 mg/ml), IL4 (Genzyme,
Cambridge, MA, 40 ng/ml) or CD40 antibody (G28.5, pro-
Polymerase chain reaction (PCR) detection of proviral
vided by E. Clark, University of Washington, Seattle; 1
DNA sequences
mg/ml) plus IL4. Cells were cultured in 6- or 24-well mac-
roplates (Falcon, Oxnard, CA) for 2 days (unless other- In vitro-infected B cells were washed twice in PBS
and DNA was extracted by a standard phenol/chloroformwise indicated) at 377 in a humidified atmosphere of 5%
CO2 and 95% air. Cells were then harvested, washed, method. The primers used to PCR were SK01 and SK39,
which generate a 755-bp amplicon from the gag gene.and subjected to HIV or mock infection. The percentage
of CD3/ cells remained below 0.5% after this preliminary One microgram of DNA was subjected to 38 or 40 cycles
of amplification, each consisting of DNA denaturationculture, whatever the stimulus used.
Secondary cultures. Infected B Cells (106 cells/ml) (947, 45 sec), annealing (57.57, 2 min), and primer exten-
sion (727, 1 min) on an Omnigene thermocycler (Hybaid,were cultured for various times up to 12 days in 96-well
microplates (Falcon) in 200 ml of medium at 377 in a Teddington, UK). Positive controls consisted of serial 10-
fold dilutions of 8E5-LAV (Folks et al., 1986) cell DNA inhumidified atmosphere of 5% CO2 and 95% air in the
presence of CD40 antibody (1 mg/ml) and/or cytokines: normal PBMC DNA ranging from 17,300 to less than 1
provirus copy per microgram of DNA. Amplification prod-IL4 (Genzyme) and IL10 (kindly provided by Schering-
Plough, Kenilworth, NJ) at 40 ng/ml, unless otherwise ucts were analyzed by 1.3% agarose gel electrophoresis.
Signal intensity was measured by densitometry to calcu-indicated, or IL2 (Biogen, Geneva, Switzerland) at 50 or
100 U/ml. The capacity of resting or activated T cells (105 late the linear relationship between the log of the copy
number and signal intensity. In all experiments, the coef-per well) to sustain viral replication was also investi-
gated. T cells were thus activated in complete medium ficient of correlation (r2) was superior to 0.9.
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Detection of HIV-1 RNA in tonsil B cells by in situ tech (Marseille, France). Results are expressed as the
mean concentration (pg/ml) of triplicate determinations.hybridization (ISH)
Probes were transcribed from the 3.18-kb SacI–KpnI RESULTS
gag-pol HIV-1 insert in pRM19 pBluescript plasmid (Va-
IL4 and IL2 mimic the effect of activated-T cells inzeux et al., 1987). The negative-strand RNA probe for
potentiating p24 production by B cellsthe messenger and/or genomic viral-positive RNA was
transcribed from pRM19 in the presence of [a-35S]UTP B cells were stimulated for 2 days prior to infection,
and T3 RNA polymerase. The positive-strand probe was infected according to the C*-ADE infection protocol and
transcribed from pRM19 in the presence of T7 RNA poly- cultured in the presence of medium alone, activated T
merase and was used as a negative control. The specific cells, or cytokines (IL4, IL2) with or without CD40 Ab for
activity of each probe was about 109 dpm/mg. up to 9 days. The concentration of p24 in the culture
For each slide, 105 cells were cytospined, fixed in 4% supernatants increased up to Day 7 and remained steady
paraformaldehyde for 10 min, and stored dehydrated at thereafter (data not shown). We thus measured the p240807 until use. Slides were thawed, acetylated, and dehy- production at Day 7 as a marker of viral production in
drated in ethanol. Hybridization was carried out at 507 subsequent experiments.
for 4 hr in a reaction mixture (5 ml/slide) containing 50% We first analyzed the effect of a stimulus prior to infec-
(v/v) deionized formamide, 10% (w/v) dextran sulfate, 300 tion on p24 production by B cells cultured for 7 days in
mM NaCl, 20 mM Tris– HCl (pH 8), 5 mM EDTA, 0.02% medium alone (Fig. 1). Viral production was highest in B
polyvinyl pyrolidone, 0.02% Ficoll, 0.02% bovine serum cells preactivated with PMA (197 pg/ml) and high in cells
albumin (BSA), 0.5 mg/ml yeast tRNA, 10 mM dithiothei- preactivated with CD40 Ab plus IL4 (114 pg/ml). The com-
trol (DTT), and 6 1 105 dpm of the probe, covered with bination of PDB and ionomycin was a less effective pre-
sterile glass coverslips, and sealed with rubber cement. activator than PMA, whereas SAC (13 pg/ml), anti-IgM
After hybridization, coverslips were removed by dipping Ab, and IL4 (below 10 pg/ml, data not shown) had little
the slides in 21 SSC (11 SSC, 150 mM NaCl, 15 mM effect. The proportion of dead cells was similar for all
sodium citrate) and the cells were extensively washed: stimuli used prior to infection. In addition, SAC induced
10 min at room temperature in 41 SSC, 10 min at 557 in B cell proliferation comparable to that induced by CD40
21 SSC, 50% formamide, 20 mM DTT, 20 min at 557 in Ab plus IL4 or phorbol esters (data not shown). Thus,
the same buffer, and finally 5 min at 557 in 21 SSC. the large effects of phorbol esters (PMA or PDB) or CD40
Residual RNA was then digested by 100 mg/ml RNAse Ab / IL4 on viral replication were not due to effects on
A in 21 SSC for 30 min at 377, and slides were washed B cell survival or proliferation.
three additional times for 10 min in 21 SSC (377) and We then tested whether the delivery of T cell-derived
0.11 SSC (557 and room temperature). The samples were signals during the secondary culture enhanced p24 pro-
then dehydrated in graded ethanol solutions. Dried slides duction by infected B cells (Fig. 1). In contrast to resting
were dipped in Amersham LM1 autoradiographic emul- T cells (data not shown), addition of PHA-activated T
sion diluted 1:2 in distilled water. They were left in the cells increased the p24 production by 3- to 10-fold, inde-
dark at 47 for exposure (3–4 weeks) and then developed pendent of the stimulus used for B cell activation. IL2
with Kodak Dektol, stained with Giemsa, mounted with stimulated p24 production by 6- to 15-fold according to
a glass coverslip, and observed microscopically with the stimulus used prior to B cell infection. On SAC and
bright-field illumination (Delord et al., 1992). H9V3 cells PDB/ionomycin-activated B cells, IL4 exerted similar in-
and mock-infected B cells were used as positive and ducing effects as IL2. Addition of CD40 Ab had little effect
negative controls, respectively. on p24 production but consistently enhanced that in-
duced by IL4. In particular, IL4 induced a 26-fold increase
Proliferation assay of p24 production by PMA-activated B cells when added
alone and a 36-fold increase when added with CD40 Ab.Proliferation was determined by pulsing cultures with
In contrast to activated T cells, neither CD40 Ab nor0.5 mCi/well of [3H]thymidine (Amersham, Les Ulis,
cytokines were able to increase p24 production by CD40France) during the last 12 hr of incubation. Cells were
Ab plus IL4 preactivated B cells.then harvested and [3H]thymidine incorporation was
Thus, phorbol esters provide a suitable preactivat-measured in a b scintillation counter (Betaplate, Beck-
ing stimulus for analyzing the regulation of HIV repli-man, France). Results are expressed as mean counts
cation in B cells infected in vitro. HIV replication wasper minute (cpm) for each triplicate test.
upregulated in B cells preactivated by SAC, but p24
production was 20-fold lower than that obtained withCytokine detection
PMA-activated B cells. In addition, p24 concentrations
obtained with anti-IgM Ab or IL4-activated cells wereTNFa production was measured in Day 2 culture su-
pernatants using a TNF-ELISA purchased from Immuno- below 20 pg/ml independent of the stimuli used post-
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FIG. 1. Activated-T cells and various soluble signals sustain HIV replication in activated B cells. B cells were stimulated for 2 days with different
activators and infected by HIV according to the C*-ADE protocol. Infected B cells (106 cells/ml) were cultured in the presence of medium, activated-
T cells, IL2 (100 U/ml), CD40 Ab, IL4 (40 ng/ml) or the combination of CD40 Ab and IL4. The p24 concentration was measured in culture supernatants
harvested on Day 7 p.i. Results are expressed as mean p24 concentration (pg/ml) in triplicate samples. SD was below 10% in this experiment. One
representative experiment of 3 is shown.
infection. Addition of IL1b, with or without soluble tion on Day 3 to p24 production on Day 7 (Fig. 2) in two
independent batches of PDB-activated B cells.CD23, or of IL6 during the secondary culture did not
enhance viral replication of PMA or SAC-activated B B cell proliferation in the presence of CD40 Ab and of
cells (data not shown). IL4 at 40 ng/ml was 31 344 { 3 963 cpm and in that of
CD40 Ab and IL4 (40 ng/ml) plus IL2 (100 U/ml) was 25
856 { 3 422 cpm (Fig. 2A). Other combinations of cyto-p24 production and cell proliferation are
kines and CD40 Ab led to moderate cell proliferationindependently regulated in HIV-infected B cells in
(below 5000 cpm), nevertheless, higher than in standardvitro
medium (211 { 32 cpm). In contrast, maximal p24 pro-
duction was obtained in the presence of IL2 plus IL4 (453Preliminary experiments showed that p24 concentration
versus 18 pg/ml in the absence of stimulus). Addition ofplateaued on Day 7 and that B cell proliferation peaked
CD40 Ab to IL2 plus IL4 reduced p24 production by 43%between Days 3 and 5 postinfection according to the cul-
(253 versus 453 pg/ml). Other combinations (IL2 aloneture conditions. To test whether the ability of infected B
and CD40 Ab in the presence of IL2 or IL4) also stimu-cells to produce higher concentrations of p24 correlated
with their ability to proliferate, we compared cell prolifera- lated viral replication (259 to 347 pg/ml), whereas CD40
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FIG. 2. HIV replication and cell proliferation are independently regulated in infected B cell populations. After a 2-day stimulation, B cells were
infected according to the C*-ADE infection protocol with either infectious virus ( ) or heat-inactivated virus (h). The B cells were then cultured in
the presence of soluble factors for various periods. (A) IL2 was used at 100 U/ml and IL4 at 40 ng/ml. (B) IL2 and IL4 were used at 50 U/ml and
20 ng/ml, respectively. [3H]Thymidine incorporation was assessed on Day 3 and p24 production was measured in supernatants harvested on Day
7. Results of proliferation are given in cpm (mean of triplicates { SD) and mean concentration of p24 (pg/ml) is given for each culture condition.
One representative experiment of 4 is shown.
Ab alone and IL4 alone had only small effects (58 and respectively, were tested on cell proliferation and p24
production (Fig. 2B). Whereas B cell proliferation in the98 pg/ml, respectively).
The effects of IL4 and IL2 at 20 ng/ml and 50 U/ml, presence of CD40 Ab plus IL4 at 40 ng/ml was maximal
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(Fig. 2A) (31,344 { 3,963 cpm), that in the presence of 0.5–1% on Day 2 p.i. and below 0.1% on Day 4. HIV-
positive cells were either clustered (Fig. 5C) or isolated20 ng/ml IL4 (Fig. 2B) was low (5,812 { 1,911 cpm).
Nevertheless, at this dose (20 ng/ml), IL4 exhibited a cells (Fig. 5D). Up to Day 4 p.i., ISH-positive B cells con-
tained high levels of viral RNA as estimated from thesynergistic effect on CD40 Ab plus IL2-induced cell prolif-
eration (13,963 { 2,856 cpm versus 4,613 { 956 cpm). signal intensity as compared to that of H9V3 T cell-posi-
tive controls (Fig. 5A).Maximal p24 production, observed in the presence of IL2
plus IL4, was also reduced by 40% after the addition of
IL10 down-regulates HIV replication in human B cellsCD40 Ab. p24 concentrations obtained in the presence
of IL2, IL2 or IL4 plus CD40 Ab were 79% (592 pg/ml), After infection, HIV- and mock-infected B cells were
70% (519 pg/ml), and 50% (376 pg/ml) of that observed cultured for 7 days with different combinations of IL2,
with IL2 plus IL4 (750 pg/ml). IL4, and CD40 Ab in the presence or absence of IL10
Similar data were obtained with PMA- and SAC-acti- (40 ng/ml). IL10 addition reduced viral replication in the
vated B cells. Thus, HIV replication and cell proliferation presence of IL2, IL4, and IL2 plus IL4 by 72, 60, and
appear to be independently regulated by these signals. 34%, respectively, without affecting p24 production in the
Indeed, even in the absence of CD40/CD40L interactions, presence of medium or CD40 Ab (Fig. 6). B cell prolifera-
viral replication was strongly promoted by IL4 and IL2, tion in the presence of IL2 plus IL4 was slightly enhanced
whereas CD40 triggering was a potent inducer of cell by IL10 addition, whereas IL2- and IL4-induced prolifera-
proliferation. HIV-infected B cells proliferated as effi- tion were reduced by 48 and 60%, respectively. In all
ciently as B cells exposed to inactivated virus (mock- cases, the addition of CD40 Ab prevented the decrease
infected cells). of cytokine-induced cell proliferation but not the de-
crease of p24 production.
TNFa production and viral replication are
independently regulated
DISCUSSION
TNFa production by mock- and HIV-infected B cell
Although in vivo infection of B cells remains to be estab-
populations was similar in different culture conditions
lished, numerous clinical observations show that B cell
(Fig. 3A). B cell proliferation correlated with TNFa pro-
differentiation is strongly impaired by HIV infection. From
duction (Fig. 3B). CD40 Ab plus IL4, with or without IL2,
the early steps of the HIV infection there are both specific
strongly stimulated HIV-infected B cell proliferation and
anti-HIV and nonspecific polyclonal B cell responses. The
TNFa production. In contrast, treatments which stimu-
nonspecific response becomes predominant and other B
lated TNFa production were different from those which
cell disorders such as hypergammaglobulinemias, hyper-
potentiated p24 production. CD40 plus IL4, in the pres-
IgE syndromes, B cell lymphomas, and altered VH reper-
ence or absence of IL2, strongly enhanced TNFa produc-
toire selection also appear (Amadori and Chieco-Bianchi,
tion but moderately stimulated p24 production. IL2 alone
1990; Berberian et al., 1993, 1991; Ditzel et al., 1994; Durie
or in combination with CD40 Ab or IL4 stimulated p24
et al., 1994; Martinez-Maza et al., 1987; Muller et al., 1993).
production but not TNFa production. This suggests that
Moreover, one group (Casareale et al., 1984) has obtained
TNFa does not directly regulate viral replication in acti-
EBV/, HIV/ B cell lines from seropositive patients and
vated B cells.
provirus expression has also been evidenced in lymphoma
cells of seropositive patients (Ford et al., 1990; Sheibani etHIV replication involves only a fraction of B cells
al., 1990; Prevot et al., 1993). In 1993, we demonstrated
that HIV may infect normal human B cells in vitro afterDNA was extracted from HIV-infected B cells cultured
for 5 days in the presence of CD40 / IL4 (Fig. 4). Semi- opsonization of the virus with anti-HIV antibodies and com-
plement. Entry of HIV into B cells requires complementquantitative PCR amplification of a viral sequence was
used to estimate the proviral load. By comparison with receptors 1 (CR1, CD35) and 2 (CR2, CD21) acting as major
receptors for HIV (Gras et al., 1993; Legendre et al., 1996).serial dilutions of DNA from the 8E5-LAV cell line (1 provi-
ral copy per cell), HIV-infected B cells contained 5 to 10 In vitro infection of normal B cells has also been observed
by two other groups, using nonopsonized virus (Poulin etHIV genomes per hundred cell genomes. Thus, 5 to 10%
at most of B cells were infected. The proviral load was al., 1994; Zhang and Henderson, 1994). They used high
input virus concentrations to infect B cells and suggestedsimilar in B cells cultured in the presence of IL2 plus IL4
(data not shown). that CD4 was involved in virus entry. These in vitro data
strengthen the hypothesis that B cell differentiation mightThe percentage of replicating B cells responsible for
virus production was estimated by ISH. ISH was per- be directly altered by HIV infection in addition to B cell
dysfunctions due to changes in environmental conditions.formed on Days 1, 2, 5, and 7 p.i. on HIV- and mock-
infected B cells cultured in the presence of IL2 plus IL4. We used our in vitro infection model to study which
exogeneous signals regulate HIV replication in B cellsAll tested cell populations were more than 80% viable.
The percentage of cells containing replicating HIV was and to what extent infection modifies B cell response.
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FIG. 3. TNFa production and viral replication are independently regulated by soluble factors in HIV-infected B cell populations. After a 2-day PDB
stimulation, B cells were infected according to the C*-ADE infection protocol with either infectious (
  
  ) or heat-inactivated (h) virus. The B cells
were then cultured in the presence of various soluble factors for various periods. TNFa production and cell proliferation were measured on Day 3
and p24 concentration was measured in supernatants harvested on Day 7. TNFa production is reported in pg/ml (mean of triplicates { SD) (A).
Correlation between TNFa production and cell proliferation (B) and p24 production (C) are shown for one representative experiment of 3. The values
of the coefficient of correlation (r 2) are indicated for B and C.
AID VY 7960 / 6a18$$7960 05-16-96 06:08:08 vira AP: Virology
316 GRAS ET AL.
FIG. 4. PCR detection of HIV provirus. B cells were stimulated by PDB for 2 days and infected then cultured in the presence of CD40 Ab plus
IL4. One microgram of DNA was subjected to PCR. (A) Uninfected B cells; (B) Mock-infected B cells, Day 4 p.i.; (C) C*-ADE-infected B cells, Day 4
p.i.; T1-6, 10-fold dilutions of 8E5-LAV cell DNA in PBMC DNA, T1 contains 17,300 proviral copies in 1 mg of DNA. Representative of three experiments.
Both resting and PMA-activated B cells are susceptible infection, with or without CD40 Ab, to increase HIV replica-
tion. Prior to infection, B cells were activated with phorbolto infection, but B cell activation prior to infection en-
hanced viral replication (Gras et al., 1993). Here, we ob- esters rather than with CD40 Ab plus IL4. Indeed, CD40
Ab plus IL4 as the first activation signal did not allow subse-served that B cell activation by phorbol esters (PMA or
PDB) and CD40 Ab plus IL4 strongly enhances subse- quent stimulation of HIV replication by CD40 Ab and/or
cytokines. This result seems to disagree with those of Pou-quent viral replication. In contrast, addition of anti-IgM
Ab, IL4, or both led to poor viral replication, similar to lin et al., but may be due to our utilization of soluble CD40
Ab rather than CD40L-transfected cells: antibody G28-5 andthat observed with resting B cells. Stimulation by SAC
induced an intermediate level of p24 production. The the natural ligand trigger different epitopes of the CD40
molecule (Fanslow et al., 1995). Indeed, addition of PHA-capacity of these different B cell activators to promote
viral replication was not strictly linked to cell proliferation: activated T cells, postinfection, enhances HIV replication in
CD40 Ab plus IL4-stimulated B cells.SAC strongly stimulated DNA synthesis, but was a poorer
inducer of viral replication than PMA. Similar percent- Once activated by phorbol esters, HIV replication was
higher in B cells cultured in the presence of activatedages of viable cells were obtained after B cell activation
by SAC, phorbol esters, and CD40 Ab plus IL4. Thus, it T cells which delivered both cell–cell interactions and
cytokines. CD40 Ab mimics interactions through CD40/is unlikely that B cell viability was involved. Phorbol es-
ters and CD40 Ab plus IL4 may enhance HIV replication CD40L and its presence increased viral replication by 2-
to 5-fold when added alone and by 7- to 14-fold within B cells through NF-KB stimulation (Bachelerie et al.,
1991; Berberich et al., 1994; Francis et al., 1995; IL4. In contrast, CD40 Ab did not enhance IL2-induced
replication and inhibited the effects of IL2 plus IL4 on viralKretschmar et al., 1992; Nabel and Baltimore, 1987).
We compared the capacities of cytokines added after replication. This suggests that CD40 signaling interfered
FIG. 5. In situ hybridization to detect HIV replicating in B cells. B cells were stimulated by PDB for 2 days and infected, then cultured in the
presence of IL2 plus IL4. (A) Chronically infected T cell line H9V3. (B) Negative control, infected B cells (Day 2 p.i.) were hybridized with the positive-
strand probe. (C) B cells showing HIV replication (Day 2 p.i.). (D) Isolated HIV-positive cells (Day 2 p.i.). Original magnification 1100.
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FIG. 6. IL10 inhibits p24 production in activated B cells. After a 2-day PDB stimulation, B cells were infected according to the C*-ADE infection
protocol. B cells were then cultured in the presence of various soluble factors with (j) or without ( ) IL10 for various periods. Cell proliferation
was measured on Day 3 and the p24 concentration was measured in supernatants harvested on Day 7. Results of proliferation are given in cpm
(mean of triplicates) and the mean concentration of p24 (pg/ml) is given for each culture condition. % of inhibition is calculated as the ratio between
the value (cpm or p24) in the presence of IL10 and the value in its absence. One representative experiment of 3 is shown.
with that of IL2 by an unknown mechanism. In vivo, IL2 on B cells cultured in the presence of medium or CD40
Ab alone. In macrophages, IL10 also inhibits HIV replica-is present during the early phases of the disease and
its concentration progressively decreases, whereas the tion (Akridge et al., 1993; Saville et al., 1994). Biochemical
data suggest that IL10 alters interleukin-induced HIV rep-local concentration of IL4 increases (Dalgleish, 1995;
Maggi et al., 1994; Mosmann, 1994). As both IL2 and IL4 lication by inhibiting NF-KB activation (Wang et al., 1995).
Thus, during the late phases of the disease, IL10 pro-enhanced HIV replication, the virus may replicate in B
cells at various stages of the disease. duced by Th2-like cells and non-T cells (Dalgleish, 1995;
Emilie et al., 1995; Masood et al., 1994) may antagonizeIL10 did not enhance viral replication even in the pres-
ence of CD40 Ab. The addition of IL10 greatly reduced IL4-induced HIV replication in B cells.
Neither the enhancing effects of IL2 and IL4 nor thep24 production induced by other cytokines independently
of the presence of CD40 Ab. However, it had no effect inhibitory effects of IL10 on HIV replication correlated
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(1991). HIV enhancer activity perpetuated by NF-Kb induction onwith cell proliferation. Indeed, the combination of IL2 and
infection of monocytes. Nature 350, 709–712.IL4, the most potent inducer of viral replication, did not
Banchereau, J., Bazan, F., Blanchard, D., Brie`re, F., Galizzi, J. P., vanincrease cell proliferation. CD40 Ab associated with IL4 Kooten, C., Liu, Y. J., Rousset, F., and Saeland, S. (1994). The CD40
or with IL4 and IL2, which strongly enhanced cell prolifer- antigen and its ligand. Annu. Rev. Immunol. 12, 881–922.
ation, only moderately induced HIV replication. Moreover, Berberian, L., Goodglick, L., Kipps, T. J., and Braun, J. (1993). Immuno-
globulin VH3 gene products: Natural ligands for HIV gp120. ScienceIL10 did not inhibit B cell proliferation induced by IL2
261, 1588–1590.plus IL4, but reduced by 34% viral replication. This sug-
Berberian, L., Valles-Ayoub, Y., Sun, N., Martinez-Maza, O., and Braun, J.gests that the effects of cytokines on HIV replication were
(1991). A VH clonal deficit in human immunodeficiency virus-positive
not consequences of the modulation of cell proliferation. individuals reflects a B-cell maturational arrest. Blood 78, 175–179.
Nevertheless the low percentage of infected B cells ob- Berberich, I., Shu, G. L., and Clark, E. A. (1994). Cross-linking CD40 on
B cells rapidly activates nuclear factor- KB. J. Immunol. 153, 4357–served in our experiments prevent definitive conclusions.
4366.Poulin et al. have reported that the proliferation of popula-
Biberfeld, P., Ost, A., Porwit, A., Standstedt, B., Pallesen, G., Bottiger,tions containing 30–50% p24/ replicating B cells was
G., Morfeld-Manson, L., and Biberfeld, G. (1987). Histopathology andlower than that of uninfected B cells (Poulin et al., 1994). immunohistology of HTLV-III/LAV related lymphadenopathy and
TNFa, like IL10, is produced in large amounts during AIDS. Acta Pathol. Microbiol. Immunol. Scand. Sect. A 95, 47–65.
the late phase of the disease (Dalgleish, 1995). In our in Butch, A. W., Gook-Hyun, C., Hoffmann, J. W., and Nahm, M. H. (1993).
Cytokine expression by germinal center cells. J. Immunol. 150, 39–vitro conditions, B cells produced small amounts of IL10
47.(below 40 pg/ml) weakly modulated by HIV infection (data
Casareale, D., Sinagil, F., Hedeskog, M., Ward, W., and Volsky, D. J.not shown). In contrast, a consistent TNFa production
(1984). Establishment of retrovirus-, Epstein–Barr virus positive B
was highest in highly proliferating B cell populations. As lymphastoid cell lines derived from individuals at risk for acquired
for cell proliferation, maximum TNFa production and p24 immune deficiency syndrome (AIDS). AIDS Res. 1, 253–270.
Dalgleish, A. G. (1995). The immune responses to HIV: Potential forproduction were obtained in the presence of different
immunotherapy. Immunol. Today 16, 356–358.signals, suggesting independent controls. In addition,
Delord, B., Ottman, M., Schrive, M. H., Ragnaud, J. M., Seigneurin, J. M.,preliminary tests suggest that addition of TNF-RII anti-
and Fleury, H. J. A. (1992). Analysis of HIV-1 expression in vivo withbody does not significantly alter p24 production induced in situ hybridization and the polymerase chain reaction. Mol. Cell.
by cytokines and/or CD40 Ab (data not shown). Probes 6, 215–221.
Comparing various activation signals used prior to in- Dierich, M. P., Ebenbichler, C. F., Marschang, P., Fust, G., Thielens,
N. M., and Arlaud, G. J. (1993). HIV and human complement: Mecha-fection, we observed that phorbol esters and the combi-
nisms of interaction and biological implication. Immunol. Today 14,nation of CD40 Ab and IL4 favored viral replication. These
435–440.effects may be linked to their ability to stimulate NF-KB
Ditzel, H. J., Barbas, S. M., Barbas, I. C. F., and Burton, D. R. (1994).
transcription factors. Similarly, we demonstrated that p24 The nature of the autoimmune antibody repertoire in human immuno-
production is regulated by various signals including deficiency virus type 1 infection. Proc. Natl. Acad. Sci. USA 91, 3710–
3714.those delivered through CD40 antigen and cytokines.
Durie, F. H., Foy, T. M., Masters, S. R., Laman, J. D., and Noelle, R. J.Among interleukins, IL2 alone or in combination with
(1994). The role of CD40 in the regulation of humoral and cell-medi-IL4 increased HIV replication, whereas IL10 essentially
ated immunity. Immunol. Today 15, 406–411.down-regulated that induced by IL2, IL4, or IL2 plus IL4.
Embretson, J., Zupancic, M., Ribas, J. L., Burke, A., Racz, P., Tenner-
The role of TNFa in disease progression is under discus- Racz, K., and Haase, A. T. (1993). Massive covert infection of helper
sion (Dalgleish, 1995). Our data suggest that it makes T lymphocytes and macrophages by HIV during the incubation period
of AIDS. Nature 362, 359–362.little contribution to HIV replication in infected B cells.
Emilie, D., Fior, R., LLorente, L., Marfaing-Koka, A., Peuchmaur, M.,These data show that HIV replication in B cells is finely
Devergne, O., Jarousse, B., Boue, F., and Galanaud, P. (1995). Cyto-tuned by signals that are also essential for plasma cell
kines from lymphoid organs of HIV-infected patients: Production and
(IL2, IL10) or memory cell (IL4 and CD40 Ab) generation role in the immune disequilibrium of the disease and in the develop-
in GC. This is particularly important since GC are the ment of B lymphomas. Immunol. Rev. 140, 6–34.
main sites of viral loading and replication (Pantaleo et Fanslow, C., Clifford, K. N., Zappone, J., Alderson, M. R., and Armitage,
R. J. (1995). CD40 mAb M2 and M3 inhibit CD4OL binding and func-al., 1993a, 1994; Schmitz et al., 1994).
tion. In ‘‘Leukocyte Typing V’’ (Schlossman et al., Eds.), p. 555. Oxford
Univ. Press.
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